Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
University of Mississippi Medical Center
mi
from
Jackson, MS
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Deborah Heart and Lung Center
mi
from
Browns Mills, NJ
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Deborah Heart and Lung Center
mi
from
Browns Mills, NJ
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Hunterdon Medical Center
mi
from
Flemington, NJ
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Hunterdon Medical Center
mi
from
Flemington, NJ
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Rutgers New Jersey Medical School
mi
from
Newark, NJ
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Rutgers New Jersey Medical School
mi
from
Newark, NJ
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Albany Vascular Group
mi
from
Albany, NY
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Albany Vascular Group
mi
from
Albany, NY
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Columbia University Medical Center
mi
from
New York, NY
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Gotham Cardiovascular Research / New York Cardiovascular Associates
mi
from
New York, NY
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Gotham Cardiovascular Research / New York Cardiovascular Associates
mi
from
New York, NY
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
UNC Health Care - Rex Hospital
mi
from
Raleigh, NC
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
UNC Health Care - Rex Hospital
mi
from
Raleigh, NC
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
OhioHealth
mi
from
Columbus, OH
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
OhioHealth
mi
from
Columbus, OH
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
UPMC Heart & Vascular Institute
mi
from
Pittsburgh, PA
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
UPMC Heart & Vascular Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Miriam Hospital
mi
from
Providence, RI
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
DFW Vascular Group
mi
from
Dallas, TX
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
DFW Vascular Group
mi
from
Dallas, TX
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Plaza Medical Center of Fort Worth
mi
from
Fort Worth, TX
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Plaza Medical Center of Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Palestine Regional Medical Center
mi
from
Palestine, TX
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Palestine Regional Medical Center
mi
from
Palestine, TX
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Mission Research Institute (Guadalupe Regional Medical Center)
mi
from
Seguin, TX
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Mission Research Institute (Guadalupe Regional Medical Center)
mi
from
Seguin, TX
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Alpine Research / Utah Cardiology
mi
from
Salt Lake City, UT
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Alpine Research / Utah Cardiology
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
University of Washington Veterans Center
mi
from
Seattle, WA
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
University of Washington Veterans Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Arkansas Heart Hospital
mi
from
Little Rock, AR
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
UMass Medical School
mi
from
Worcester, MA
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
UMass Medical School
mi
from
Worcester, MA
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Wellmont CVA Heart Institute
mi
from
Kingsport, TN
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Wellmont CVA Heart Institute
mi
from
Kingsport, TN
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Pima Vascular
mi
from
Tucson, AZ
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Pima Vascular
mi
from
Tucson, AZ
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
Hattiesburg Clinic
mi
from
Hattiesburg, MS
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
Hattiesburg Clinic
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated:  3/6/2018
St.Louis University Hospital
mi
from
Saint Louis, MO
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
Delivery of Dexamethasone to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
Status: Enrolling
Updated: 3/6/2018
St.Louis University Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated:  3/6/2018
Arkansas Heart Hospital
mi
from
Little Rock, AR
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated: 3/6/2018
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated:  3/6/2018
Endovascular Technologies (Willis Knighton Medical Center)
mi
from
Bossier City, LA
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated: 3/6/2018
Endovascular Technologies (Willis Knighton Medical Center)
mi
from
Bossier City, LA
Click here to add this to my saved trials
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated:  3/6/2018
Mission Research Institute LLC
mi
from
New Braunfels, TX
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated: 3/6/2018
Mission Research Institute LLC
mi
from
New Braunfels, TX
Click here to add this to my saved trials
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated:  3/6/2018
Palestine Regional Medical Center
mi
from
Palestine, TX
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated: 3/6/2018
Palestine Regional Medical Center
mi
from
Palestine, TX
Click here to add this to my saved trials
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated:  3/6/2018
Rex Hospital, Inc
mi
from
Raleigh, NC
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated: 3/6/2018
Rex Hospital, Inc
mi
from
Raleigh, NC
Click here to add this to my saved trials
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated:  3/6/2018
Hattiesburg Clinic
mi
from
Hattiesburg, MS
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
Status: Enrolling
Updated: 3/6/2018
Hattiesburg Clinic
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Barbara Davis Center / University of Colorado Denver
mi
from
Aurora, CO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Barbara Davis Center / University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Kaiser Permanente Colorado Institute for Health Research
mi
from
Denver, CO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Kaiser Permanente Colorado Institute for Health Research
mi
from
Denver, CO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Atlanta Diabetes Associates
mi
from
Atlanta, GA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Joslin Diabetes Center
mi
from
Boston, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
University of Massachusetts Memorial Health Care
mi
from
Worcester, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
University of Massachusetts Memorial Health Care
mi
from
Worcester, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Brehm Center for Diabetes Research / University of Michigan
mi
from
Ann Arbor, MI
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Brehm Center for Diabetes Research / University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Univ of Minnesota
mi
from
Minneapolis, MN
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Albert Einstein College of Medicine/ Montefiore Medical Center
mi
from
Bronx, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Albert Einstein College of Medicine/ Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Jacobi Medical Center
mi
from
Bronx, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Winthrop University Hospital
mi
from
Mineola, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Univ of Washington
mi
from
Seattle, WA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Providence Sacred Heart Medical Center
mi
from
Spokane, WA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Providence Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Henry Ford Health System
mi
from
Detroit, MI
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Weill Cornell Medical Center
mi
from
New York, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials